The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Relationship between Antibiotic Resistance, Biofilm Formation, and Biofilm-Specific Resistance in Acinetobacter baumannii
Open accessAbstract
In this study, we aimed to examine the relationships between antibiotic resistance, biofilm formation, and biofilm-specific resistance in clinical isolates of Acinetobacter baumannii. The tested 272 isolates were collected from several hospitals in China during 2010-2013. Biofilm-forming capacities were evaluated using the crystal violet staining method. Antibiotic resistance/susceptibility profiles to 21 antibiotics were assessed using VITEK 2 system, broth microdilution method or the Kirby-Bauer disc diffusion method. The minimum inhibitory concentration (MIC) and minimum biofilm eradication concentration (MBEC) to cefotaxime, imipenem, and ciprofloxacin were evaluated using micro dilution assays. Genetic relatedness of the isolates was also analyzed by pulsed-field gel electrophoresis (PFGE) and plasmid profile. Among all the 272 isolates, 31 were multidrug-resistant (MDR), and 166 were extensively drug-resistant (XDR). PFGE typing revealed 167 pattern types and 103 clusters with a similarity of 80%. MDR and XDR isolates built up the main prevalent genotypes. Most of the non-MDR isolates were distributed in a scattered pattern. Additionally, 249 isolates exhibited biofilm formation, among which 63 were stronger biofilm formers than type strain ATCC19606. Population that exhibited more robust biofilm formation likely contained larger proportion of non-MDR isolates. Isolates with higher level of resistance tended to form weaker biofilms. The MBECs for cefotaxime, imipenem, and ciprofloxacin showed a positive correlation with corresponding MICs, while the enhancement in resistance occurred independent of the quantity of biofilm biomass produced. Results from this study imply that biofilm acts as a mechanism for bacteria to get a better survival, especially in isolates with resistance level not high enough. Moreover, even though biofilms formed by isolates with high level of resistance are always weak, they could still provide similar level of protection for the isolates. Further explorations genetically would improve our understanding of these processes and provide novel insights in the therapeutics and prevention against A. baumannii biofilm-related infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
Bergogne-Bérézin, E., & Towner, K. J. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.2.148 · Cited by 1,711
Aminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Microtiter Dish Biofilm Formation Assay
O'Toole, G. A. (2011) · Journal of Visualized Experiments · doi:10.3791/2437 · Cited by 1,108
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Spoering, A. L., & Lewis, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6746-6751.2001 · Cited by 902
Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal
McDougald, D., Rice, S. A., Barraud, N., Steinberg, P. D., & Kjelleberg, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2695 · Cited by 881
Non-inherited antibiotic resistance
Levin, B. R., & Rozen, D. E. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1445 · Cited by 542
O'Neill, E., Pozzi, C., Houston, P., Humphreys, H., Robinson, D. A., Loughman, A., Foster, T. J., & O'Gara, J. P. (2008) · Journal of Bacteriology · doi:10.1128/jb.00167-08 · Cited by 496
Bacterial resistance to antibiotics: The role of biofilms
Hoyle, B. D., & Costerton, J. W. (1991) · Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques · doi:10.1007/978-3-0348-7139-6_2 · Cited by 449
Antibiotic-Induced Biofilm Formation
Kaplan, J. B. (2011) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000027 · Cited by 397
Lee, H.-W., Koh, Y. M., Kim, J., Lee, J.-C., Lee, Y.-C., Seol, S.-Y., Cho, D.-T., & Kim, J. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01842.x · Cited by 323
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications
Rodríguez-Baño, J., Martí, S., Soto, S., Fernández-Cuenca, F., Cisneros, J. M., Pachón, J., Pascual, A., Martínez-Martínez, L., McQueary, C., Actis, L. A., et al. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01916.x · Cited by 248
Karch, H., Heesemann, J., Laufs, R., O'Brien, A. D., Tacket, C. O., & Levine, M. M. (1987) · Infection and Immunity · doi:10.1128/iai.55.2.455-461.1987 · Cited by 200
Insights into Acinetobacter baumannii pathogenicity
Cerqueira, G. M., & Peleg, A. Y. (2011) · IUBMB Life · doi:10.1002/iub.533 · Cited by 192
Bhattacharyya, P., Gurung, J., Khyriem, A. B., Banik, A., Lyngdoh, W. V., & Choudhury, B. (2013) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.118416 · Cited by 132
Abidi, S. H., Sherwani, S. K., Siddiqui, T. R., Bashir, A., & Kazmi, S. U. (2013) · BMC Ophthalmology · doi:10.1186/1471-2415-13-57 · Cited by 129
Common β‐lactamases inhibit bacterial biofilm formation
Gallant, C. V., Daniels, C. E., Leung, J. M., Ghosh, A. S., Young, K. D., Kotra, L. P., & Burrows, L. L. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04892.x · Cited by 124
Evolution of multi-resistance plasmids in Australian clinical isolates of Escherichia coli
Sherley, M., Gordon, D. M., & Collignon, P. (2004) · Microbiology · doi:10.1099/mic.0.26773-0 · Cited by 76
Why are we afraid of Acinetobacter baumannii?
Pérez, F., Endimiani, A., & Bonomo, R. A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.3.269 · Cited by 54
Heteroresistance to Cephalosporins and Penicillins in Acinetobacter baumannii
Hung, K., Wang, M.-C., Huang, A.-H., Yan, J.-J., & Wu, J.-J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05085-11 · Cited by 44
Cited by
Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications
Periferakis, A., Periferakis, K., Badarau, I. A., Petran, E. M., Popa, D. C., Caruntu, A., Costache, R. S., Scheau, C., Caruntu, C., & Costache, D. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315054 · Cited by 362
Asif, M., Alvi, I. A., & Rehman, S. U. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s166750 · Cited by 333
Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria
Cepas, V., López, Y., Muñoz, E., Rolo, D., Ardanuy, C., Martí, S., Xercavins, M., Horcajada, J. P., Bosch, J., & Soto, S. M. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0027 · Cited by 326
Eze, E., Chenia, H., & El Zowalaty, M. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s169894 · Cited by 264
Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation
Yang, C.-H., Su, P.-W., Moi, S.-H., & Chuang, L.-Y. (2019) · Molecules · doi:10.3390/molecules24101849 · Cited by 259
Metadata
- Authors
- Qi, L., Li, H., Zhang, C., Liang, B., Li, J., Wang, L., Du, X., Liu, X., Qiu, S., & Song, H.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2016-04-12
- Volume
- 7
- Pages
- 483-483
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2329075805
- Cited by
- 368
- References
- 24
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.